​

Cadrenal Therapeutics (CVKD) Revenue & Revenue Breakdown

OverviewFinancialsChart

Cadrenal Therapeutics Revenue Highlights

00

Cadrenal Therapeutics Revenue by Period

Cadrenal Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31--

Cadrenal Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Cadrenal Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$2.13K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.77K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31--

Cadrenal Therapeutics generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Cadrenal Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CASICASI Pharmaceuticals$33.88M$3.41M
CLGNCollPlant Bio$10.96M$98.00K
XCURExicure$500.00K-
SONNSonnet BioTherapeutics$147.81K-
KLTOKlotho Neurosciences--
BOLDBoundless Bio--
ENLVEnlivex Therapeutics--
PASGPassage Bio--
CVKDCadrenal Therapeutics--
NRSNNeuroSense Therapeutics--

CVKD Revenue FAQ

What is Cadrenal Therapeutics’s yearly revenue?

Cadrenal Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. CVKD's yearly revenue for 2022 was $0, representing an increase of 0% compared to 2021.

What is Cadrenal Therapeutics’s quarterly revenue?

Cadrenal Therapeutics's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). CVKD's quarterly revenue for Q4 2024 was $2.13K, a 100.00% increase from the previous quarter (Q3 2024), and a -22.90% decrease year-over-year (Q4 2023).

What is Cadrenal Therapeutics’s revenue growth rate?

Cadrenal Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%